In October 2013, the physicians in charge of the Mississippi baby's antiretroviral therapy reported that at 30 months, 12 months after antiretroviral therapy stopped, HIV levels in the child were found to be below detectable levels.
Robert F. Siliciano hypothesized that the infant girl received antiretroviral therapy before producing memory T cells, which are immune cells that can serve as a viral reservoir for HIV.